2/6
08:03 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock, up previously from $21.00.
Medium
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock, up previously from $21.00.
2/6
06:35 am
adpt
Rating for ADPT
High
Report
Rating for ADPT
1/26
11:23 am
adpt
Rating for ADPT
Low
Report
Rating for ADPT
1/26
11:23 am
adpt
Rating for ADPT
Low
Report
Rating for ADPT
1/26
10:59 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/26
10:59 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Guggenheim.
11/11
11:29 am
adpt
Rating for ADPT
Low
Report
Rating for ADPT
11/11
11:29 am
adpt
Rating for ADPT
Low
Report
Rating for ADPT